Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials

Bibliographic Details
Title: Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials
Authors: Abiola Ibraheem, Colin Pillai, Ifeoma Okoye, J. Joshua Smith, Diane Reidy-Lagunes, Grace Macaulay, Olusegun Alatise
Source: JCO Global Oncology, Vol , Iss 7, Pp 1358-1363 (2021)
Publisher Information: American Society of Clinical Oncology, 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a platform where innovative targeted therapies can be made available to patients in the environ. In the 2019 African Organization for Research and Training in Cancer (AORTIC) conference held at Maputo, Mozambique, a group of clinical trialists spanning across multiple continents highlighted the opportunities in Africa for the conduct of cancer clinical trials. The secondary purpose of the meeting was to address the belief that Africa was incapable of conducting interventional cancer trials but showed the in-continent strengths, such as available capacities, trained local clinical trialists with clinical trial experiences, clinical trial consortia, local capabilities, mapping out logistics, ethical consideration, political will, real-time benefits of clinical trials to clinical practice, and future directions for trials.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2687-8941
Relation: https://doaj.org/toc/2687-8941
DOI: 10.1200/GO.21.00096
Access URL: https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187
Accession Number: edsdoj.5b0f95750cc344848f9b5b7a75b76187
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=26878941&ISBN=&volume=7&issue=7&date=20211201&spage=1358&pages=1358-1363&title=JCO Global Oncology&atitle=Cancer%20Clinical%20Trials%20in%20Africa%E2%80%94An%20Untapped%20Opportunity%3A%20Recommendations%20From%20AORTIC%202019%20Conference%20Special%20Interest%20Group%20in%20Clinical%20Trials&aulast=Abiola%20Ibraheem&id=DOI:10.1200/GO.21.00096
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.5b0f95750cc344848f9b5b7a75b76187
RelevancyScore: 957
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 956.691040039063
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Abiola+Ibraheem%22">Abiola Ibraheem</searchLink><br /><searchLink fieldCode="AR" term="%22Colin+Pillai%22">Colin Pillai</searchLink><br /><searchLink fieldCode="AR" term="%22Ifeoma+Okoye%22">Ifeoma Okoye</searchLink><br /><searchLink fieldCode="AR" term="%22J%2E+Joshua+Smith%22">J. Joshua Smith</searchLink><br /><searchLink fieldCode="AR" term="%22Diane+Reidy-Lagunes%22">Diane Reidy-Lagunes</searchLink><br /><searchLink fieldCode="AR" term="%22Grace+Macaulay%22">Grace Macaulay</searchLink><br /><searchLink fieldCode="AR" term="%22Olusegun+Alatise%22">Olusegun Alatise</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: JCO Global Oncology, Vol , Iss 7, Pp 1358-1363 (2021)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: American Society of Clinical Oncology, 2021.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2021
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a platform where innovative targeted therapies can be made available to patients in the environ. In the 2019 African Organization for Research and Training in Cancer (AORTIC) conference held at Maputo, Mozambique, a group of clinical trialists spanning across multiple continents highlighted the opportunities in Africa for the conduct of cancer clinical trials. The secondary purpose of the meeting was to address the belief that Africa was incapable of conducting interventional cancer trials but showed the in-continent strengths, such as available capacities, trained local clinical trialists with clinical trial experiences, clinical trial consortia, local capabilities, mapping out logistics, ethical consideration, political will, real-time benefits of clinical trials to clinical practice, and future directions for trials.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2687-8941
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/2687-8941
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1200/GO.21.00096
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187" linkWindow="_blank">https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.5b0f95750cc344848f9b5b7a75b76187
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.5b0f95750cc344848f9b5b7a75b76187
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/GO.21.00096
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1358
    Subjects:
      – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
        Type: general
      – SubjectFull: RC254-282
        Type: general
    Titles:
      – TitleFull: Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abiola Ibraheem
      – PersonEntity:
          Name:
            NameFull: Colin Pillai
      – PersonEntity:
          Name:
            NameFull: Ifeoma Okoye
      – PersonEntity:
          Name:
            NameFull: J. Joshua Smith
      – PersonEntity:
          Name:
            NameFull: Diane Reidy-Lagunes
      – PersonEntity:
          Name:
            NameFull: Grace Macaulay
      – PersonEntity:
          Name:
            NameFull: Olusegun Alatise
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 26878941
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JCO Global Oncology
              Type: main
ResultId 1